AGS/AAO Comments to the FDA on Generics
The AGS and AAO recently became aware of proposed revisions to current standards and procedures for ensuring bioequivalence of ophthalmic emulsions, suspensions and ointments.
Our societies have concerns regarding the safety and rationale of the proposed changes outlined in the Federal Register Notice and the risks that might be encountered by patients under our care if these procedures were to be enacted.
Learn More